Vitreous Tamponades are postoperative tools used in retinal detachment vitrectomy procedures. http://www.theprimitiveoldecrow.com/advisingeyesurgeon/2016/11/01/standards-for-effective-solutions-in-eye-bags/Retinal detachment is a very serious medical complication and, if not treated on time, can lead to permanent loss of vision. In the United States about 6% of population is estimated to suffer from retinal breaks, with annual incidences of 1 in 10,000. Vitrectomy is a surgical technique used in the correction of retinal detachment, which involves the removal of small amounts of vitreous gel from the human eye. At the end of vitrectomy, tamponades are injected into the eye to hold the retina in place and help in the healing process. There is unmet market need for safe and technologically superior devices. Mergers and acquisitions are some of the key strategies adopted by leading industry players. For instance, in the year 2011, Novartis acquired Alcon Incorporated, a global leader in eye care. no dataThe companies profiled in the report include: Alcon, Inc. D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.
For the original version including any supplementary images or video, visit http://www.businesswire.com/news/home/20161103006456/en/World-Vitreous-Tamponades-Market-Report-2014-2022–